Zydus Lifesciences Ltd.

View in App
615.85 -8.65 ▼-1.4%

21 September 2023, 04:01:00 PM
Volume: 47,448

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.zyduscadila.com
Market Cap 62,306.23 Cr.
Enterprise Value(EV) 62,896.33 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 24.98 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 24.65 Trailing Twelve Months Ending 2023-06
Industry PE 37.95 Trailing Twelve Months Ending 2023-06
Book Value / Share 184.04 Trailing Twelve Months Ending 2023-06
Price to Book Value 3.35 Calculated using Price: 615.85
Dividend Yield 0.97 Period Ending 2023-03
No. of Shares Subscribed 101.22 Cr. 1,012,204,139 Shares
FaceValue 1
About Zydus Lifesciences Ltd.
The company is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain of innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), active pharmaceutical ingredients (APIs), animal healthcare products and consumer wellness products. Innovation is the backbone of the company as it ensures business sustainability through continuous availability of new products for various businesses.

Zydus Lifesciences Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Zydus Lifesciences Ltd. Performance

View details >>
1 Day
-1.39%
1 Week
-3.73%
1 Month
-5.76%
3 Month
+9.93%
6 Month
+28.85%
1 Year
+68.08%
2 Year
+11.94%
5 Year
+55.91%
10 Year
+349.99%

Zydus Lifesciences Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 30.85 38.62 23.47 22.50 19.36 11.32 18.88 15.51 11.60
Return on Capital Employed (%) 23.21 28.60 16.52 18.55 15.89 10.02 14.38 15.30 13.64
Return on Assets (%) 13.93 20.14 12.20 11.23 9.34 5.18 9.66 9.40 7.82

Zydus Lifesciences Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 3,439 4,252 5,699 6,960 8,745 10,386 10,376 12,992 17,000 17,516
Non Curr. Liab. 1,589 1,342 736 1,903 2,122 3,491 2,854 19 -194 -725
Curr. Liab. 2,814 3,285 3,461 5,306 6,072 7,343 8,269 7,861 7,827 5,527
Minority Int. 144 169 136 156 191 1,293 1,335 1,937 2,054 2,173
Equity & Liab. 7,987 9,047 10,032 14,325 17,141 22,513 22,834 22,810 26,700 24,494
Non Curr. Assets 4,549 4,820 5,752 8,303 8,911 14,015 14,118 14,094 14,438 14,478
Curr. Assets 3,438 4,227 4,280 6,022 8,201 8,498 8,715 8,716 12,095 10,008
Misc. Exp. not W/O
Total Assets 7,987 9,047 10,032 14,325 17,141 22,513 22,834 22,810 26,700 24,494

Zydus Lifesciences Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 8,651 9,427 9,377 11,905 13,166 14,253 14,404 15,110 17,237 18,647
Other Income 57 117 147 133 209 117 75 391 475 157
Total Income 8,709 9,543 9,524 12,038 13,374 14,370 14,479 15,501 17,712 18,804
Total Expenditure -6,897 -7,097 -7,472 -9,058 -10,187 -11,473 -11,018 -11,935 -13,666 -14,115
PBIDT 1,811 2,446 2,051 2,980 3,187 2,897 3,460 3,565 4,047 4,689
Interest -68 -53 -63 -111 -196 -342 -186 -127 -130 -114
Depreciation -287 -292 -373 -539 -599 -697 -670 -713 -723 -722
Taxation -259 -177 -129 -564 -530 -320 -194 -512 -588 -686
Exceptional Items -10 -3 0 -10 -364 -205 113 -604 -616
PAT 1,186 1,921 1,486 1,766 1,852 1,176 2,206 2,326 2,002 2,552
Minority Interest -38 -30 -29 -35 -50 -28 -51 -131 -132 -120
Share Associate 43 34 63 47 29 47 46 95 94
Other Related Items 2
Consolidated Net Profit 1,151 1,934 1,488 1,776 1,849 1,177 2,134 4,487 1,960 2,529
Adjusted EPS 11 19 15 17 18 11 21 44 19 25

Zydus Lifesciences Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 903 994 1,894 1,312 919 1,282 2,932 3,294 2,105 2,689
Cash Fr. Inv. -438 -465 -864 -2,872 -974 -4,239 -1,012 -725 -1,000 1,171
Cash Fr. Finan. -529 -351 -935 2,316 52 1,885 -1,528 -2,548 -868 -4,400
Net Change -64 178 95 756 -3 -1,072 391 22 236 -540
Cash & Cash Eqvt 613 790 837 1,593 1,590 779 1,178 1,087 1,107 573

Zydus Lifesciences Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 74.88 74.88 74.88 74.88 74.88 74.98 74.98 74.98 74.98
Public 25.12 25.12 25.12 25.12 25.12 25.02 25.02 25.02 25.02
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Zydus Lifesciences Ltd. Announcements

View details >>
Wed, 20 Sep 2023
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from the USFDA for Clindamycin Phosphate Gel USP 1%.
Wed, 20 Sep 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
The Company is going to participate in an investor conference J.P. Morgan India Investor Summit 2023 at Mumbai on Monday September 25 2023.
Tue, 19 Sep 2023
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives EIR for the formulation manufacturing facility at SEZ 2 Ahmedabad

Zydus Lifesciences Ltd. Technical Scans

View details >>
Thu, 21 Sep 2023
Close Crossing Last Week Low Close Crossing Last Week Low
Close Crossing Last Month Low Close Crossing Last Month Low
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Below Last Week Low Close Below Last Week Low

Zydus Lifesciences Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 274,963.79 1,148.50 -0.4%
Divi's Laboratories Ltd. 99,404.71 3,741.45 -1.0%
Cipla Ltd. 97,455.33 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. 94,594.48 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. 72,171.99 5,023.50 +0.4%
Mankind Pharma Ltd. 69,708.40 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. 63,451.75 1,874.80 -0.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.67 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-06 67.23 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-06 31.32 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 20.07 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 108.04 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 54.38 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 50.36 1,874.80 -0.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.75 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-06 7.57 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-06 4.00 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.86 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.52 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 5.69 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.65 1,874.80 -0.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-03 0.02 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,874.80 -0.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,874.80 -0.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,874.80 -0.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,874.80 -0.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,874.80 -0.5%

Zydus Lifesciences Ltd. FAQ's

What is Zydus Lifesciences share price?
Can I buy Zydus Lifesciences shares now?
What is the Dividend Yield of Zydus Lifesciences?
What is the Market Cap of Zydus Lifesciences?
What are the key metrics to analyse Zydus Lifesciences?
What is the 52 Week High and Low of Zydus Lifesciences?
What is the trend of Zydus Lifesciences share price?